Q-omics provides the consensus-scored SSX8P profile across patient tissues and cancer cell-line models. SSX8P expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, SSX8P is differentially expressed in 4, with the highest sampling consensus in THCA. Additionally, SSX8P RNA expression shows 8,848 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, THCA, and THYM as cancer lineages where SSX8P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SSX8P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SSX8P survival associations across molecular data types. SSX8P RNA expression shows survival associations in the most cancer types (14), followed by mutation status (4). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SSX8P RNA expression–survival associations across cancer types. High SSX8P expression shows unfavorable associations in KIRC, KICH, READ, LUAD and PCPG, but favorable associations in THCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for SSX8P RNA expression.
This table summarizes SSX8P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for SSX8P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SSX8P shows lower tumor expression in BRCA and higher tumor expression in THCA, LIHC and KIRC. The THCA box plot shows higher SSX8P RNA expression in tumor versus normal tissue (log2 FC = +0.320, t-test p < 0.001).
This table shows molecular features associated with SSX8P in patient tissues and cancer cell lines. In patient samples, SSX8P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set. In cancer cell lines, SSX8P RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_SCLC, while CRISPR and shRNA rows add functional-dependency signals in LIVER.
